Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations

Urinary Tract Injury During Hysterectomy Based on Universal Cystoscopy

(2014) Okechukwu A. Ibeanu et al.   OBSTETRICS AND GYNECOLOGY

Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening in 1077 Women After BRCA Testing

(2012) Gabriel N. Mannis et al.   JAMA Internal Medicine

Cancer Risk Management Decisions of Women with BRCA1 or BRCA2 Variants of Uncertain Significance

(2011) Kaylene Ready et al.   Breast Journal

Long-term outcomes ofBRCA1/BRCA2testing: risk reduction and surveillance

(2011) Marc D. Schwartz et al.   CANCER

Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: Variant reclassification and surgical decisions

(2011) Mitzi L. Murray et al.   GENETICS IN MEDICINE

Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers

(2009) Mary S. Beattie et al.   Genetic Testing and Molecular Biomarkers

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

(2008) Kelly A. Metcalfe et al.   INTERNATIONAL JOURNAL OF CANCER

Predictors of Contralateral Prophylactic Mastectomy in Women With a BRCA1 or BRCA2 Mutation: The Hereditary Breast Cancer Clinical Study Group

(2008) Kelly A. Metcalfe et al.   JOURNAL OF CLINICAL ONCOLOGY